Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Sanofi SA    SNY

Delayed Quote. Delayed  - 07/27 10:02:02 pm
42.43 USD   +0.76%
02:13a SANOFI : Receives FDA Approval of AdlyxinTM for Treatment of Adults ..
01:46a SANOFI : ​Sanofi Receives FDA Approval of AdlyxinTM for Treatm..
01:45a SANOFI : Receives FDA Approval of AdlyxinTM for Treatment of Adults ..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Sanofi SA
Engages in the research, production and distribution of pharmaceutical products

Sanofi engages in the research, production and distribution of pharmaceutical products.

It operates through the following segments: Pharmaceuticals, Human Vaccines, and Animal Health.

The Pharmaceuticals segment includes research, development, production and sales activities relating to pharmaceutical products, including prescription, consumer health care, and generic products.

This segment also includes equity affiliates and joint ventures with pharmaceutical business activities.

The Human Vaccines segment includes research, development, production and marketing of vaccines.

The Animal Health segment comprises the research, development, production and marketing activities for Merial, which offers a range of medicines and vaccines for a wide variety of animal species.The company was founded on April 28, 1994 and is headquartered in Paris, France.

Number of employees : 115 631 persons.
Sales per Businesses
20142015Delta
USD (in Million)%USD (in Million)%
Pharmaceuticals36,62882.1%32,88886.3% -10.21%
Vaccines5,25111.8%5,23513.7% -0.31%
Animal Health2,7436.1%---
Sales per Regions
20142015Delta
USD (in Million)%USD (in Million)%
Other Countries15,13333.9%13,05634.2% -13.73%
United States14,98333.6%13,51535.5% -9.79%
Europe10,48123.5%8,40222% -19.83%
France3,2697.3%2,4816.5% -24.1%
North America755.811.7%667.711.8% -11.66%
Managers
NameAgeSinceTitle
Olivier Brandicourt MD, PhD602015Chief Executive Officer & Director
Serge Weinberg652009Chairman
Jérôme Contamine592009Chief Financial Officer & EVP-Finance
Elias E. Zerhouni, MD652011President-Global Research & Development
Yong-Jun Liu MD, PhD-2016Head-Global Research & Development
Ameet Nathwani MD, MBA-2016Group Chief Medical Officer & Executive VP
Robert Castaigne, PhD702000Independent Director
Jean-René Fourtou772004Independent Director
Claudie Haigneré MD, PhD592008Independent Director
Uwe Bicker MD, PhD712008Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Share A 1 1,305,696,759 1,148,224,649 87.9% 3,956,708 0.3% 87.9%
Shareholders
NameEquities%
Dodge & Cox 53,530,129 2.08%
Barrow, Hanley, Mewhinney & Strauss LLC 29,087,790 1.13%
Franklin Advisers, Inc. 20,831,192 0.81%
Fisher Asset Management LLC 13,638,183 0.53%
Fidelity Management & Research Co. 10,245,712 0.40%
Hotchkis & Wiley Capital Management LLC 10,164,994 0.39%
Invesco Advisers, Inc. 5,947,863 0.23%
Harris Associates LP 5,571,835 0.22%
Berkshire Hathaway, Inc. (Investment Management) 3,905,875 0.15%
Delaware Management Business Trust 3,767,285 0.15%
Holdings
NameEquities%Valuation
Regeneron Pharmaceuticals Inc (REGN) 23,418,39622.7%8,178,406,435 USD
Aventis Pharma Limited (AVPH) 13,909,58760.4%913,999,657 USD
Alnylam Pharmaceuticals, Inc. (ALNY) 10,256,63312.0%569,140,565 USD
Sanofi (SAN) 3,956,7080.31%329,326,184 USD
Zentiva SA (ROSCD) 312,341,64974.9%136,577,633 USD
Myokardia Inc (MYOK) 3,218,89911.9%39,914,348 USD
Voyager Therapeutics Inc (VYGR) 2,477,9419.26%27,232,572 USD
Immune Design Corp (IMDZ) 917,4294.55%7,486,221 USD
Proteome Sciences plc (PRM) 38,0000.017%7,112 USD
Nichi-iko Pharmaceutical Co., Ltd. (4541) 500.0001%1,011 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Sector Pharmaceuticals - NEC
1st jan.Capitalization (M$)
SANOFI SA-1.27%108 516
JOHNSON & JOHNSON21.84%344 243
PFIZER INC.14.10%223 368
NOVARTIS AG-5.30%219 971
ROCHE HOLDING LTD.-9.99%218 902
MERCK & CO., INC.10.49%161 542
BRISTOL-MYERS SQUIBB C..9.11%125 298
NOVO NORDISK A/S-7.35%113 407
SANOFI-2.58%108 516
GLAXOSMITHKLINE PLC20.68%106 688
ALLERGAN PLC-20.34%98 474
ELI LILLY AND CO-2.58%90 668
BAYER AG-19.20%85 080
ASTRAZENECA PLC0.48%77 078
ABBOTT LABORATORIES-2.92%64 055
SHIRE PLC4.45%57 958
TEVA PHARMACEUTICAL IN..-17.64%49 556
ASTELLAS PHARMA INC-0.96%34 523
TAKEDA PHARMACEUTICAL ..-24.20%33 799
MYLAN NV-14.04%23 629
CHUGAI PHARMACEUTICAL ..-5.76%20 604
Sector Pharmaceuticals - NEC
Sanofi SA : Connections
National Committee on United States-China Relations, Inc.
Aventis Foundation
Montres CORUM Sàrl
Fondation Lacoste
Maremma SASU
Institute of Medicine
Alliance Automotive Group SAS
The Children's Aid Society, Inc.
Financières SASA
Academie des Sports
Piasa SA
Académie Nationale de Médecine
MedImmune LLC
Madrigall SA
Bordeaux University Foundation
Fondation C.Génial
L'Oréal Corporate Foundation
Council on Foreign Relations, Inc.
Académie des Sciences et Technologies
Sanofi-Aventis Europe SAS
Piasa Holding SAS
Sanofi-Aventis Participations SA
National Academy of Engineering
The Johns Hopkins University
International Federation of Pharmaceutical Manufacturers A
Sanofi-Aventis U.S. LLC
Pharmaceutical Research & Manufacturers of America
Financière Piasa SAS
Sanofi Pasteur Holding SA
Fondation de France
Sanofi Pasteur Holding & Merial Ltd.
Pres héSam
Fondation pour l’Université de Lyon
Weinberg Capital Partners SAS
Académie des Technologies
Research!America
Academie de l'air et de l'espace
King Abdullah University of Science & Technology
Philipps University of Marburg
Warp Drive Bio LLC
Ruprecht-Karls-Universität Heidelberg
Company contact information
Sanofi
54, rue La Boétie
Paris, Ile-de-France 75008

Phone : +33.1.53.77.40.00
Fax : +33.1.53.77.44.63
Web : www.sanofi.com
© 2016 People , Fundamentals and Ownership